Belgian pharmaceutical company UCB SA has sued drug-maker Teva Pharmaceutical Industries to stop it manufacturing a generic version of epilepsy drug Vimpat.
If you have already subscribed please login.
If you have any technical issues please email tech support.
ucb, teva, anda, vimpat, lacosamide
Receive daily emails from WIPR